0001104659-25-123721.txt : 20251222 0001104659-25-123721.hdr.sgml : 20251222 20251222161023 ACCESSION NUMBER: 0001104659-25-123721 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20251218 FILED AS OF DATE: 20251222 DATE AS OF CHANGE: 20251222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Doyle John Brendan CENTRAL INDEX KEY: 0001840738 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40886 FILM NUMBER: 251592540 MAIL ADDRESS: STREET 1: C/O CHIASMA INC. STREET 2: 140 KENDRICK STREET BUILDING C EAST CITY: NEEDHAM STATE: MA ZIP: 20494 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COGNITION THERAPEUTICS INC CENTRAL INDEX KEY: 0001455365 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2500 WESTCHESTER AVE CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 412-481-2210 MAIL ADDRESS: STREET 1: 2500 WESTCHESTER AVE CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: COGNITION THERAPUTICS INC DATE OF NAME CHANGE: 20090204 4 1 tm2534021-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2025-12-18 0 0001455365 COGNITION THERAPEUTICS INC CGTX 0001840738 Doyle John Brendan C/O COGNITION THERAPEUTICS INC 2500 WESTCHESTER AVE. PURCHASE NY 10577 0 1 0 0 Chief Financial Officer 0 Common Stock 2025-12-18 4 A 0 30000 0.00 A 455350 D Common Stock 2025-12-18 4 F 0 9360 1.50 D 445990 D Shares earned upon the vesting of performance stock units ("PSUs") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. The remaining 50% of the total number of shares subject to the PSUs vested on December 18, 2025. Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs. /s/ John Brendan Doyle 2025-12-22